SG Americas Securities, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 259 filers reported holding ACCELERON PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.4%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,877,000
-12.0%
10,909
-35.8%
0.01%
-10.0%
Q2 2021$2,132,000
-3.5%
16,986
+4.2%
0.01%
-16.7%
Q1 2021$2,210,000
+1525.0%
16,299
+1431.9%
0.01%
+1100.0%
Q4 2020$136,000
-83.5%
1,064
-85.4%
0.00%
-80.0%
Q3 2020$822,000
+319.4%
7,308
+254.4%
0.01%
+150.0%
Q2 2020$196,000
-95.8%
2,062
-96.1%
0.00%
-95.5%
Q1 2020$4,708,000
+1226.2%
52,385
+682.0%
0.04%
+1366.7%
Q4 2019$355,000
+219.8%
6,699
+139.2%
0.00%
+200.0%
Q3 2019$111,000
-75.4%
2,801
-74.6%
0.00%
-66.7%
Q2 2019$452,000
-37.0%
11,015
-28.5%
0.00%
-57.1%
Q1 2019$717,000
-58.0%
15,398
-60.7%
0.01%
-53.3%
Q4 2018$1,707,000
+1607.0%
39,188
+1794.1%
0.02%
+1400.0%
Q2 2018$100,000
-8.3%
2,069
-25.6%
0.00%0.0%
Q1 2018$109,000
-76.1%
2,782
-77.3%
0.00%
-75.0%
Q3 2017$457,000
+221.8%
12,239
+161.9%
0.00%
+300.0%
Q2 2017$142,000
+10.1%
4,673
-3.9%
0.00%0.0%
Q1 2017$129,000
-69.1%
4,864
-70.3%
0.00%
-75.0%
Q4 2016$417,000
+30.3%
16,350
+84.8%
0.00%
+33.3%
Q3 2016$320,000
+114.8%
8,849
+56.8%
0.00%
+200.0%
Q1 2016$149,000
+4.2%
5,642
+25.0%
0.00%0.0%
Q2 2015$143,000
-9.5%
4,513
+11.3%
0.00%0.0%
Q4 2014$158,000
-50.3%
4,054
-56.1%
0.00%0.0%
Q1 2014$318,0009,2280.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders